Trial intelligence / Profile preview

Preoperative Tazocin for acute cholecystitis undergoing acute cholecystectomy

2009-010265-23Phase 4Active

Sponsor
Gastrocentrum
Start
Mar 2009
Modality
Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in acute cholecystitis comparing Preoperative Tazocin with Preoperative placebo (2 arms). Primary endpoint: Reduction in positive biliary bacterial cultures. Started Mar 2009; status: active.

02

Drugs

piperacillin + tazobactam
03

Conditions

acute cholecystitis

Beyond the preview

Go deeper on 2009-010265-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010265-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call